Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway

INTRODUCTION: The objective of this work was to evaluate the efficacy of placenta-derived mesenchymal stem cell (MSC) therapy in a mouse model of myocardial infarction (MI). Since MSCs can be obtained from two different regions of the human term placenta (chorionic plate or villi), cells obtained fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Passipieri, Juliana A, Kasai-Brunswick, Tais H, Suhett, Grazielle, Martins, Andreza B, Brasil, Guilherme V, Campos, Dilza B, Rocha, Nazareth N, Ramos, Isalira P, Mello, Debora B, Rodrigues, Deivid C, Christie, Beatriz B, Silva-Mendes, Bernardo J, Balduíno, Alex, Sá, Renato M, Lopes, Laudelino M, Goldenberg, Regina C, Campos de Carvalho, Antonio C, Carvalho, Adriana B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354978/
https://www.ncbi.nlm.nih.gov/pubmed/25145631
http://dx.doi.org/10.1186/scrt490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354978/
https://www.ncbi.nlm.nih.gov/pubmed/25145631
http://dx.doi.org/10.1186/scrt490

Ejemplares similares